课题基金 / 基金详情

FEND for TB

FEND for TB
FEND 防治结核病
批准号:
10654567
负责人:
David Alland
金额:
$394.33万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-06-04 至 2025-05-31
关键词:

项目摘要

项目成果

David Alland的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT In response to RFA-AI-19-030, Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND-TB) the leadership team has brought together a consortium of experienced investigators and clinical sites and developed a research plan to address critical unmet TB diagnostic needs. This program benefits from experience gained during the successful 7-year tenure of the NIH DMID-funded TB-Clinical Diagnostics Research Consortium (TB-CDRC), with overlap in leadership, investigators and sites. This program has been adapted in several ways to further enhance capacity to meet the current challenges in the field -- the successful collaboration with the Foundation for Innovative New Diagnostics (FIND) has been strengthened to now a full partnership that will facilitate access to cutting edge technologies and alignment of FEND-TB work with global stakeholder priorities; clinical study sites in India and Peru have been added to accelerate recruitment and augment capacity to enroll patients with co-morbidities and drug- resistance; inclusion of a mature analytic laboratory and revised technology evaluation strategy that together allow for rational, nimble, step-wise evaluation of early-stage diagnostics; and inclusion of mathematical modeling capacity to inform optimal diagnostic strategies in TB endemic settings. This proposal will test two main hypotheses: A. Novel early stage TB diagnostics, that target bacterial and/or host targets and will be ready for evaluation in the next five years, will have performance characteristics suitable for point of care (POC)/near-care use for TB detection, triage, or drug susceptibility testing. B. Rapid non-sputum diagnostics will provide ancillary support as components of algorithms for the diagnosis of childhood TB as well as paucibacillary pulmonary TB and extrapulmonary TB in adults. Specific Aims are: 1. To evaluate the diagnostic accuracy of early stage diagnostic tests for tuberculosis. 2. To identify new early stage diagnostics for evaluation, and to develop and implement for each a stepwise evaluation plan. 3. To use economic analysis and transmission modelling to design optimal diagnostic algorithms.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1016/j.jctube.2023.100362
发表时间: 2023
期刊: Journal of clinical tuberculosis and other mycobacterial diseases
影响因子: 2
作者: [Nsubuga,Gideon, Kennedy,Samuel, Rani,Yasha, Hafiz,Zibran, Kim,Soyeon, Ruhwald,Morten, Alland,David, Ellner,Jerrold, Joloba,Moses, Dorman,SusanE, Penn-Nicholson,Adam, Nakiyingi,Lydia]
通讯作者: Nakiyingi,Lydia
Resources, Workforce Development, and Animal Models for the Rutgers RBL
Supplement to G20AI67347 to complete critical upgrades to the Rutgers RBL
  • 批准号:
    10631469
  • 项目类别:
  • 资助金额:
    $191.33万
  • 财政年份:
    2022
  • 负责人:
    David Alland
  • 依托单位:
Key Facility Upgrades for the Rutgers University RBL.
  • 批准号:
    10393791
  • 项目类别:
  • 资助金额:
    $332.84万
  • 财政年份:
    2021
  • 负责人:
    David Alland
  • 依托单位:
Bacterial and Host Heterogeneity in TB latency, persistence and progression
  • 批准号:
    10493254
  • 项目类别:
  • 资助金额:
    $265.83万
  • 财政年份:
    2021
  • 负责人:
    David Alland
  • 依托单位:
海外基金